Log In
Print
BCIQ
Print
Print this Print this
 

BMS-817378

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionSmall molecule that inhibits c-Met proto-oncogene (MET;HGFR) and VEGF receptor 2 (KDR/Flk-1; VEGFR-2)
Molecular Target c-Met proto-oncogene (MET) (HGFR) ; Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2)
Mechanism of ActionVascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) kinase inhibitor; MET inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner

Simcere Pharmaceutical Group


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today